Dr. Daniel Fuller Jones, MD Pathology - Clinical Pathology Medicare: Medicare Enrolled Practice Location: 11 E Athens Ave Unit 308, Ardmore, PA 19003 Phone: 802-734-8052 |
News Archive
The new decade may herald an era of cell therapy - treating human diseases by delivering highly specific beneficial cells. In the wake of an NIH decision late last year permitting federally funded researchers to use new lines of human embryonic stem cells, the door has opened more widely to stem cell research.
Interventional Spine, Inc. today announced the FDA clearance of their next generation Opticage Expandable Interbody Fusion Device. The next generation system is an enhanced version of the original Opticage system that was introduced in 2012.
An expansion of health insurance to more U.S. residents - with "business, patients and government sharing the cost" - is important, but unless "we find cures, American families will continue to be plagued by costly and debilitating fatal diseases such as cancer, diabetes and Alzheimer's" disease, former Rep. Harold Ford (D-Tenn.), chair of the Democratic Leadership Council, and Al From, founder and CEO of the council, write in a Memphis Commercial Appeal opinion piece.
Researchers at Kanazawa University report in EMBO Reports, 7 December 2017, new molecular mechanisms regulating cellular fate of squamous cell carcinomas.
› Verified 9 days ago